Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033, growing at ...
(MENAFN- GlobeNewsWire - Nasdaq) Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in ...
Circular plasmid DNA has traditionally been used as a stable and efficient vector for gene expression and HDR-mediated gene insertion. These vectors typically carry at least one antibiotic-resistant ...
DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...
Astute Analytica released an extensive market assessment report titled “Global Viral vectors & plasmid DNA manufacturing market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033.” ...
This study is led by Prof. Qunxin She (Shandong University) and Dr. Guanhua Yuan (Shandong University). The research group has constructed versatile genetic tools for Saccharolobus islandicus REY15A, ...
(MENAFN- GlobeNewsWire - Nasdaq) The surge is fueled by a rapidly expanding gene and cell therapy pipeline, with over 4,000 therapies in development and more than 2,000 active clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results